Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Open Forum Infectious Diseases
|
March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative
Kimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
The Journal of Infectious Diseases
|
February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
Sahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Plos One
|
April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study
Behzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Journal of Infectious Diseases
|
April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study
Rachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study
Behzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Journal of Infectious Diseases
|
August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infection
Jessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Jason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic
Charles S Berenson, Bret Lashner, Louis Y Korman, et al.
Gastroenterology
|
August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
Matthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Nature Medicine
|
January 6, 2026
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome
Jessica A Bryant, Marin Vulić, Emily A Walsh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Open Forum Infectious Diseases
|
March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative
Kimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
The Journal of Infectious Diseases
|
February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
Sahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Plos One
|
April 4, 2015
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study
Behzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Journal of Infectious Diseases
|
April 18, 2015
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study
Rachel Sacks-Davis, Jason Grebely, Gregory J Dore, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 27, 2014
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study
Behzad Hajarizadeh, Bart Grady, Kimberly Page, et al.
The Journal of Infectious Diseases
|
August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infection
Jessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
Jason Grebely, Kimberly Page, Rachel Sacks-Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic
Charles S Berenson, Bret Lashner, Louis Y Korman, et al.
Gastroenterology
|
August 9, 2020
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
Matthew R Henn, Edward J O'Brien, Liyang Diao, et al.
Nature Medicine
|
January 6, 2026
The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome
Jessica A Bryant, Marin Vulić, Emily A Walsh, et al.
Page
of 4